FOXO3 and ovarian carcinoma: Although several studies have revealed that FoxO1 and FoxO3a play important roles in increasing the drug resistance in various diseases, such as ovarian cancer and chronic myelogenous leukemia [41,42], drug resistance studies involving FoxO1 and FoxO3a in melanoma have not yet been conducted, so further studies are needed to investigate this.